comoR: A software for disease comorbidity risk assessment

Journal of Clinical Bioinformatics

Volumn 4, Issue 1, 2014, Pages

  Moni, Mohammad Ali ^a,b   Liò, Pietro ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PABNA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Bangladesh)

Author keywords

Comorbidities; Disease associations; Relative risk

Indexed keywords

EID: 84988810041     PISSN: None     EISSN: 20439113     Source Type: Journal    
DOI: 10.1186/2043-9113-4-8     Document Type: Article

References (44)

1. Capobianco E, Liò P: Comorbidity: a multidimensional approach. Trends MolMed 2013, 19(9):515-521
2. Radner H, Yoshida K, Smolen JS, Solomon DH: Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity. Nat Rev Rheumatol 2014
3. Park J, Lee DS, Christakis NA, Barabási AL: The impact of cellular networks on disease comorbidity. Mol Syst Biol 2009, 5:1
4. Hidalgo CA, Blumm N, Barabási AL, Christakis NA: A dynamic network approach for the study of human phenotypes. PLoS Comput Biol 2009, 5(4):e1000353
5. Tong B, Stevenson C: Comorbidity of cardiovascular disease, diabetes and chronic kidney disease in Australia. Cardiovascular Disease Series no. 28. Cat. no. CVD 37: Australian Institute of Health & Welfare, Canberra; 2007
6. Liò P, Paoletti N, Moni MA, Atwell K, Merelli E, Viceconti M: Modelling osteomyelitis. BMC bioinformatics 2012, 13(Suppl 14):S12
7. Kumar MSA, Sierka DR, Damask AM, Fyfe B, Mcalack RF, Heifets M, Moritz MJ, Alvarez D, Kumar A: Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int 2005, 67(4):1622-1629
8. de Jager DJ, Vervloet MG, Dekker FW: Noncardiovascularmortality in CKD: an epidemiological perspective. Nat Rev Nephrol 2014, 10(4):208-214
9. Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, Dewey FE, Dudley JT, Ormond KE, Pavlovic A, Morgan AA: Clinical assessment incorporating a personal genome. The Lancet 2010, 375(9725):1525-1535
10. Schriml LM, Arze C, Nadendla S, Chang YWW, Mazaitis M, Felix V, Feng G, Kibbe WA: Disease Ontology: a backbone for disease semantic integration. Nucleic Acids Res 2012, 40(D1):D940-D946
11. Lagro J, Melis RJ, Rikkert MGO: Importance of comorbidity in competing risks analysis in patients with localized renal cell carcinoma. J Clin Oncol 2010, 28(18):e298-e298
12. Hall SF, Rochon PA, Streiner DL, Paszat LF, Groome PA, Rohland SL: Measuring comorbidity in patients with head and neck cancer. The Laryngoscope 2002, 112(11):1988-1996
13. Ferrandina G, Lucidi A, Paglia A, Corrado G, Macchia G, Tagliaferri L, Fanfani F, Morganti AG, Valentini V, Scambia G: Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: impact on outcome and treatment-related complications. Eur J Surg Oncol (EJSO) 2012, 38(3):238-244
14. Lin Y, Wang S, Chappell RJ: Lasso tree for cancer staging with survival data. Biostatistics 2013, 14(2):327-339
15. Annest A, Bumgarner RE, Raftery AE, Yeung KY: The iterative bayesian model averaging algorithm for survival analysis: an improved method for gene selection and survival analysis on microarray data. 2010
16. Oberthuer A, Kaderali L, Kahlert Y, Hero B, Westermann F, Berthold F, Brors B, Eils R, Fischer M: Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR. Clin Cancer Res 2008, 14(20):6590-6601
17. Haibe-Kains B, Schröder M, Olsen C, Sotiriou C, Bontempi G, Quackenbush J, de Montréal RC: Survcomp: a package for performance assessment and comparison for survival analysis. 2013, 27(22):3206-3208
18. Cho H, Yu A, Kim S, Kang J, Hong SM: Robust likelihood-based survival modeling formicroarray data. J Stat Softw 2009, 29(i01). (American Statistical Association)
19. Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS: Random survival forests. Ann Appl Stat 2008:841-860. (JSTOR)
20. Therneau T: Package survival. R Project 2013
21. Yasrebi H: SurvJamda: an R package to predict patients' survival and risk assessment using joint analysis of microarray gene expression data. Bioinformatics 2011, 27(8):1168-1169
22. Lopez-de Ullibarri I, Jácome MA: survPresmooth: an R package for presmoothed estimation in survival analysis. J Stat Softw 2013, 54(11):1-26
23. Colchero F, Jones O, Rebke M, Colchero MF: Package BaSTA. Methods Ecol Evol 2013, 3(3):466-470
24. Kan WC, Wang JJ, Wang SY, Sun YM, Hung CY, Chu CC, Lu CL, Weng SF, Chio CC, Chien CC: The new Comorbidity Index for predicting survival in elderly dialysis patients: a long-term population-based study. PloS one 2013, 8(8):e68748
25. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5(10):R80
26. Yu G, Wang LG: Disease ontology semantic and enrichment analysis. 2012
27. McKusick VA: Mendelian inheritance inman and its online version, OMIM. Am J Human Genet 2007, 80(4):588
28. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL: The human disease network. Proc Nat Acad Sci 2007, 104(21):8685-8690
29. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M: KEGG for representation and analysis ofmolecular networks involving diseases and drugs. Nucleic Acids Res 2010, 38(suppl 1):D355-D360
30. Wang JZ, Du Z, Payattakool R, Philip SY, Chen CF: A new method to measure the semantic similarity of GO terms. Bioinformatics 2007, 23(10):1274-1281
31. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Nat Acad Sci USA 2005, 102(43):15545-15550
32. Du P, Feng G, Flatow J, Song J, Holko M, Kibbe WA, Lin SM: From disease ontology to disease-ontology lite: statisticalmethods to adapt a general-purpose ontology for the test of gene-ontology associations. Bioinformatics 2009, 25(12):i63-i68
33. Kalisch M, Mächler M, Colombo D, Maathuis MH, Bühlmann P: Causal inference using graphicalmodels with the R package pcalg. J Stat Softw 2012, 47(11):1-26
34. Katz D, Baptista J, Azen S, Pike M: Obtaining confidence intervals for the risk ratio in cohort studies. Biometrics 1978:469-474. (JSTOR)
35. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992, 45(6):613-619
36. Elixhauser A, Steiner C, Harris DR, Coffey RM: Comorbidity measures for use with administrative data. Med Care 1998, 36:8-27
37. Zhang W, Ota T, Shridhar V, Chien J, Wu B, Kuang R: Network-based Survival Analysis Reveals Subnetwork Signatures for Predicting Outcomes of Ovarian Cancer Treatment. PLoS Comput Biol 2013, 9(3):e1002975
38. Bowker SL, Majumdar SR, Veugelers P, Johnson JA: Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006, 29(2):254-258
39. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Nat Acad Sci USA 2005, 102(38):13550-13555
40. Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE: Experimentally derivedmetastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology 2010, 138(3):958-968
41. Bonome T, Levine DA, Shih J, Randonovich M, Pise-Masison CA, Bogomolniy F, Ozbun L, Brady J, Barrett JC, Boyd J: A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. Cancer Res 2008, 68(13):5478-5486
42. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, Cornella H, Liberzon A, Kobayashi M, Kumada H: Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma. Gastroenterology 2011, 140(5):1501-1512
43. Buddingh EP, Kuijjer ML, Duim RA, Bürger H, Agelopoulos K, Myklebost O, Serra M, Mertens F, Hogendoorn PC, Lankester AC: Tumor-infiltrating macrophages are associated with metastasis suppression in highgrade osteosarcoma: a rationale for treatment withmacrophage activating agents. Clinical Cancer Research 2011, 17(8):2110-2119
44. Ullman-Cullere MH, Mathew JP: Emerging landscape of genomics in the electronic health record for personalized medicine. HumMutat 2011, 32(5):512-516